In tumor entities derived from cell types normally negative for E-Cadherin (n = 29; Fig. 2c), a weak to strong E-Cadherin positivity could be detected in at least 10% of cases in 15 different tumor entities (51.7%). Here, CDH1 is linked to neoplasm.